Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature
1Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
2School of Pharmacy, University of Nizwa, Nizwa, Sultanate of Oman.
Open Access
Published:  May 18, 2022
The success and sustainability of any profession can be evident during times of crises. Clinical pharmacists adapted and adopted multiple roles, which were an extension of their routine activities including a few new activities depending on the situation demands. Numerous studies in the literature discussed the various roles played and the activities offered by clinical pharmacists during the coronavirus disease of 2019 (COVID-19) pandemic. The challenges and opportunities faced by the clinical pharmacists during this time are worth contemplating. We aimed to summarize the challenges faced by clinical pharmacists during the pandemic and the opportunities that arose. Providing direct patient care, change in scheduling, and burnout were among the top challenges. Telehealth services and participation in guideline development and education were among the prominent opportunities. A discouraging finding was the lack of adequate recognition along with other front-line workers. The pandemic was a clear indicator of the significant role a clinical pharmacist plays in the healthcare team. Measures need to be taken by clinical pharmacists to ensure authorities are well-informed of their activities. It is also recommended to incorporate these experiences in pharmacy degree programs to ensure that pharmacists are better prepared for any future health or natural crises.
Thabit AK, Jose J. Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature. J Appl Pharm Sci, 2022. Online First.
Aburas W, Alshammari TM. Pharmacists' roles in emergency and disasters: COVID-19 as an example. Saudi Pharm J, 2020; 28(12):1797- 816. https://doi.org/10.1016/j.jsps.2020.11.006 | |
Al-Quteimat Om Msc B, Amer Am R.Ph M. SARS-CoV-2 outbreak: how can pharmacists help? Res Social Adm Pharm, 2021; 17(2):480-2. https://doi.org/10.1016/j.sapharm.2020.03.018 | |
Al Ammari M, AlThiab K, AlJohani M, Sultana K, Maklhafi N, AlOnazi H, Maringa A. Tele-pharmacy anticoagulation clinic during COVID-19 pandemic: patient outcomes. Front Pharmacol, 2021; 12:652482. https://doi.org/10.3389/fphar.2021.652482 | |
Alhamad H, Abu-Farha R, Albahar F, Jaber D. Public perceptions about pharmacists' role in prescribing, providing education and delivering medications during COVID-19 pandemic era. Int J Clin Pract, 2021; 75(4):e13890. https://doi.org/10.1111/ijcp.13890 | |
Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med, 2020; 46(5):854-87. https://doi.org/10.1007/s00134-020-06022-5 | |
Allison A, Shahan J, Goodner J, Smith L, Sweet C. Providing essential clinical pharmacy services during a pandemic: virtual video rounding and precepting. Am J Health Syst Pharm, 2021; 78(17):1556-8. https://doi.org/10.1093/ajhp/zxab208 | |
Alwhaibi RA, Alrwaished A, Binobydaan SM, Alawwad S, Wajid S, Bablghaith S, Alghadeer S, Al Arifi MN. Role of pharmacist during COVID-19 pandemic: a retrospective study focused on critically ill COVID-19 patients. Saudi Pharm J, 2021; 29(9):1050-5. https://doi.org/10.1016/j.jsps.2021.07.010 | |
Andrade J, Slaby M, DeAngelis J, Connors J, Truong J, Ciaramella C, DiGregorio R. Implementation of a pharmacist-led COVID-19 vaccination clinic at a community teaching hospital. Am J Health Syst Pharm, 2021; 78(12):1038-42. https://doi.org/10.1093/ajhp/zxab135 | |
Arain S, Thalapparambath R, Al Ghamdi FH. COVID-19 pandemic: response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department. Res Social Adm Pharm, 2021; 17(1):2009-11. https://doi.org/10.1016/j.sapharm.2020.05.016 | |
Aruru M, Truong HA, Clark S. Pharmacy emergency preparedness and response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond. Res Social Adm Pharm, 2021; 17(1):1967-77. https://doi.org/10.1016/j.sapharm.2020.04.002 | |
Ashiru-Oredope D, Kerr F, Hughes S, Urch J, Lanzman M, Yau T, Cockburn A, Patel R, Sheikh A, Gormley C, Chavda A, Vaghela T, Phillips C, Reid N, Brady A. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiotics (Basel), 2021; 10(2):110. https://doi.org/10.3390/antibiotics10020110 | |
Assiri A, Iqbal MJ, Gramish J, Assiri A, Meraya A, Alhossan A, Khobrani M. Pharmacists' satisfaction with their involvement in the management of COVID-19 patients in Saudi Arabia. Saudi Pharm J, 2021; 29(1):85-90. https://doi.org/10.1016/j.jsps.2020.12.009 | |
Badr AF, Ismail GA, Alghuraybi RH, Lahza RZ. Expanding pharmacist's educational role using virtual and Social media portals before and during COVID-19 outbreak. Saudi Pharm J, [Online ahead of print], 2021; 29(6):533-8. https://doi.org/10.1016/j.jsps.2021.04.014 | |
Barlow B, Barlow A, Newsome AS. Comment on Gross and MacDougall "Roles of the clinical pharmacist during the COVID-19 pandemic". J Am Coll Clin Pharm, 2020. | |
Bauman JL. Hero clinical pharmacists and the COVID-19 pandemic: overworked and overlooked. J Am Coll Clin Pharm, 2020. https://doi.org/10.1002/jac5.1246 | |
Bhat S, Farraye FA, Moss AC. Impact of clinical pharmacists in inflammatory bowel disease centers during the COVID-19 pandemic. Am J Gastroenterol, 2020; 115(9):1532-3. https://doi.org/10.14309/ajg.0000000000000787 | |
Bhat S, Kehasse A. Additional clinical pharmacists roles during COVID-19. J Am Coll Clin Pharm, 2020. | |
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis, 2020. https://doi.org/10.1093/cid/ciaa478 | |
Chahine EB. The role of pharmacists in the fight against COVID-19. Sr Care Pharm, 2020; 35(7):286-91. https://doi.org/10.4140/TCP.n.2020.286 | |
Cheng V, Abdul-Aziz MH, Roberts JA, Shekar K. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. J Thorac Dis, 2018; 10(Suppl 5):S629-41. https://doi.org/10.21037/jtd.2017.09.154 | |
Cheong MWL. 'To be or not to be in the ward': the impact of COVID-19 on the role of hospital-based clinical pharmacists-a qualitative study. J Am Coll Clin Pharm, 2020. https://doi.org/10.1002/jac5.1315 | |
Cope R, Fischetti B, Eladghm N, Elaskandrany M, Karam N. Outpatient management of chronic warfarin therapy at a pharmacistrun anticoagulation clinic during the COVID-19 pandemic. J Thromb Thrombolysis, 2021. https://doi.org/10.1007/s11239-021-02410-w | |
Damuzzo V, Bertin R, Mengato D, Chiumente M, Rivano M, Palozzo AC. Hospital pharmacy response to COVID-19 pandemic in Italy: what we learned from the first outbreak wave. J Pharm Pract, 2021; 8971900211023643. https://doi.org/10.1177/08971900211023643 | |
Danelich IM, Thomson L, Alberto J, Bonanni S, Buckler R, Foley J, Phillips S, Rall B, Thoma B, Merli G, Wordell, C. Adaptation of clinical pharmacy services to meet patient care needs during the COVID-19 pandemic. J Am Coll Clin Pharm, 2021; 4(3):364-71. https://doi.org/10.1002/jac5.1392 | |
De Val J, Sohal G, Sarwar A, Ahmed H, Singh I, Coleman JJ. Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic. Eur J Hosp Pharm, 2021; 28(1):10-15. https://doi.org/10.1136/ejhpharm-2020-002364 | |
Do T, Luon S, Boothe K, Stutsky M, Renauer M. Advancing ambulatory pharmacy practice through a crisis: Objectives and strategies used in an ambulatory care action team's response to the COVID-19 pandemic. Am J Health Syst Pharm, 2021; 78(8):720-5. https://doi.org/10.1093/ajhp/zxab063 | |
Elnaem MH, Cheema E. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists. Res Social Adm Pharm, 2021; 17(1):1938-41. https://doi.org/10.1016/j.sapharm.2020.05.030 | |
Erstad BL. Caring for the COVID patient: a clinical pharmacist's perspective. Ann Pharmacother, 2021; 55(3):413-4. https://doi.org/10.1177/1060028020954224 | |
Faine BA, Carroll E, Decleene J, Zepeski A. Airway management team for patients with COVID-19: a new role for emergency medicine pharmacists. Am J Health Syst Pharm, 2020; 77(14):1102-3. https://doi.org/10.1093/ajhp/zxaa129 | |
Ferguson NC, Quinn NJ, Khalique S, Sinnett M, Eisen L, Goriacko P. Clinical pharmacists: an invaluable part of the coronavirus disease 2019 frontline response. Crit Care Explor, 2020; 2(10):e0243. https://doi.org/10.1097/CCE.0000000000000243 | |
Goff DA, Ashiru-Oredope D, Cairns KA, Eljaaly K, Gauthier TP, Langford BJ, Mahmoud SF, Messina AP, Michael UC, Saad T, Schellack, N. Global contributions of pharmacists during the COVID-19 pandemic. J Am Coll Clin Pharm, 2020. | |
Gourieux B, Reisz F, Belmas AS, Danion F, Fourtage M, Nai T, Reiter-Schatz A, Ruch Y, Walther J, Nivoix Y, Michel B. Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital. Eur J Hosp Pharm, 2021; 28(5):242-7. https://doi.org/10.1136/ejhpharm-2020-002449 | |
Gross A, MacDougall C. Roles of the clinical pharmacist during the COVID-19 pandemic. J Am Coll Clin Pharm, 2020; 3(3):564-6. https://doi.org/10.1002/jac5.1231 | |
Gurnani PK, Peksa GD, Panos NG, DeMott JM. Under the microscope: a look into the role of critical care pharmacists during the COVID-19 pandemic. J Pharm Pract, 2021; 8971900211013991. https://doi.org/10.1177/08971900211013991 | |
Herzik KA, Bethishou L. The impact of COVID-19 on pharmacy transitions of care services. Res Social Adm Pharm, 2021; 17(1):1908-12. https://doi.org/10.1016/j.sapharm.2020.10.017 | |
Hussain K, Ambreen G, Muzammil M, Raza SS, Ali U. Pharmacy services during COVID-19 pandemic: experience from a tertiary care teaching hospital in Pakistan. J Pharm Policy Pract, 2020; 13(1):74. https://doi.org/10.1186/s40545-020-00277-5 | |
Iftinan GN, Wathoni N, Lestari K. Telepharmacy: a potential alternative approach for diabetic patients during the COVID-19 pandemic. J Multidiscip Healthc, 2021; 14:2261-73. https://doi.org/10.2147/JMDH.S325645 | |
Johnston K, O'Reilly CL, Cooper G, Mitchell I. The burden of COVID-19 on pharmacists. J Am Pharm Assoc (2003), 2020. https://doi.org/10.1016/j.japh.2020.10.013 | |
Jordan D, Guiu-Segura JM, Sousa-Pinto G, Wang LN. How COVID-19 has impacted the role of pharmacists around the world. Farm Hosp, 2021; 45(2):89-95. | |
Kjerengtroen S, Wilde SM, Fontaine GV, Forbush KM, Van Gorder CM, Wohlt P. COVID-19 preparedness: Clinical pharmacy services remote staffing in a quaternary, level I trauma and comprehensive stroke center. Am J Health Syst Pharm, 2020; 77(15):1250-6. https://doi.org/10.1093/ajhp/zxaa132 | |
Lemtiri J, Matusik E, Cousein E, Lambiotte F, Elbeki N. The role of the critical care pharmacist during the COVID-19 pandemic. Ann Pharm Fr, 2020; 78(6):464-8. https://doi.org/10.1016/j.pharma.2020.09.001 | |
Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm, 2021; 17(1):1813-8. https://doi.org/10.1016/j.sapharm.2020.04.003 | |
Manohar KN, Parashar N, Kumar CRS, Verma V, Rao S, Sekhar Y, Vijay Kumar K, Amalselvam A, Hemkumar TR, Prem Kumar BN, Sridhar K, Pradeep Kumar S, Sangeeta K, Shivam, Kumar C, Judith. Prevalence and severity of secondary traumatic stress and optimism in Indian health care professionals during COVID-19 lockdown. PLoS One, 2021; 16(9):e0257429. https://doi.org/10.1371/journal.pone.0257429 | |
Marchese M, Heintzman A, Pasetka M, Charbonneau F, DeAngelis C, Peragine C. Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic. J Oncol Pharm Pract, 2021; 27(3):650-7. https://doi.org/10.1177/1078155221991202 | |
McNamara A, Zhao M, Lee SY. Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits. J Am Coll Clin Pharm, 2021; 4(8):914-23. https://doi.org/10.1002/jac5.1487 | |
Meng L, Huang J, Qiu F, Sun S. Roles of the Chinese clinical pharmacist during the COVID-19 pandemic. J Am Coll Clin Pharm, 2020. | |
Merks P, Jakubowska M, Drelich E, Swieczkowski D, Bogusz J, Bilmin K, Sola KF, May A, Majchrowska A, Koziol M, Pawlikowski J, Jaguszewski M, Vaillancourt R. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Social Adm Pharm, 2021; 17(1):1807-12. https://doi.org/10.1016/j.sapharm.2020.05.033 | |
Moreau C. The pharmacist as part of the primary care team during the COVID-19 pandemic. J Am Board Fam Med, 2021; 34(Suppl):S21-5. https://doi.org/10.3122/jabfm.2021.S1.200180 | |
Moye RA, Mason K, Flatt A, Faircloth B, Livermore J, Brown B, Furr A, Starnes C, Yates JR, Hurt R. Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice model. Am J Health Syst Pharm, 2021; 78(8):705-11. https://doi.org/10.1093/ajhp/zxab015 | |
Muflih SM, Al-Azzam S, Abuhammad S, Jaradat SK, Karasneh R, Shawaqfeh MS. Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19. Int J Clin Pract, 2021; 75(7):e14209. https://doi.org/10.1111/ijcp.14209 | |
National Institute of Health. COVID-19 treatment guidelines. The National Institutes of Health, Bethesda, MD, 2020. Available via https://covid19treatmentguidelines.nih.gov/ | |
Park L, Kim JH, Waldman G, Marks CR, Clark JE. Impact analysis of virtual ambulatory transplant pharmacists during COVID-19. J Am Coll Clin Pharm, 2021; 4(8):978-87. https://doi.org/10.1002/jac5.1488 | |
Patel C, Dalton L, Dey A, Macartney K, Beard F. Letter: impact of the COVID-19 pandemic on pharmacist-administered vaccination services. Res Social Adm Pharm, 2021; 17(1):2040-1. https://doi.org/10.1016/j.sapharm.2020.08.021 | |
Paudyal V, Cadogan C, Fialova D, Henman MC, Hazen A, Okuyan B, Lutters M, Stewart D. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Social Adm Pharm, 2020; 17(8):1507-17. https://doi.org/10.1016/j.sapharm.2020.11.017 | |
Perez M, Masse M, Deldicque A, Beuscart JB, De Groote P, Desbordes J, Fry S, Musy E, Odou P, Puisieux F, Lambert M, Scherpereel A, Decaudin B. Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital. Eur J Hosp Pharm, 2022; 29(e1):e30-5. https://doi.org/10.1136/ejhpharm-2020-002542 | |
Segal EM, Alwan L, Pitney C, Taketa C, Indorf, A., Held, L., Lee KS, Son M, Chi M, Diamantides E, Gosser, R. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. Am J Health Syst Pharm, 2020; 77(17):1403-8. https://doi.org/10.1093/ajhp/zxaa184 | |
Skalafouris C, Samer C, Stirnemann J, Grosgurin O, Eggimann F, Grauser D, Reny JL, Bonnabry P, Guignard, B. Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19. Eur J Hosp Pharm, 2021. https://doi.org/10.1136/ejhpharm-2020-002667 | |
Song Z, Hu Y, Zheng S, Yang L, Zhao R. Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience. Res Social Adm Pharm, 2021; 17(1):2027-31. https://doi.org/10.1016/j.sapharm.2020.03.027 | |
Srirangan K, Lavenue A. Helping Quebec pharmacists seize the vaccination service opportunity: the pharmacy best practice workshops. Pharmacy (Basel), 2021; 9(1). https://doi.org/10.3390/pharmacy9010051 | |
Surapat B, Sungkanuparph S, Kirdlarp S, Lekpittaya N, Chunnguleum K. Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19). J Clin Pharm Ther, 2021; 46(1):236-9. https://doi.org/10.1111/jcpt.13293 | |
Thomas AM, Baker JW, Hoffmann TJ, Lamb K. Clinical pharmacy specialists providing consistent comprehensive medication management with increased efficiency through telemedicine during the COVID19 pandemic. J Am Coll Clin Pharm, 2021; 4(8):934-8. https://doi.org/10.1002/jac5.1494 | |
Thong KS, Selvaratanam M, Tan CP, Cheah MF, Oh HL, Lee PM, Chew CC, Chang CT, Lee JCY. Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital. J Pharm Policy Pract, 2021; 14(1):61. https://doi.org/10.1186/s40545-021-00343-6 | |
Thorakkattil SA, Nemr HS, Al-Ghamdi FH, Jabbour RJ, AlQaaneh AM. Structural and operational redesigning of patient-centered ambulatory care pharmacy services and its effectiveness during the COVID-19 pandemic. Res Social Adm Pharm, 2021; 17(1):1838-44. https://doi.org/10.1016/j.sapharm.2020.06.017 | |
Traynor K. ICU pharmacist describes challenges in COVID-19 care. Am J Health Syst Pharm, 2020; 77(15):1183-4. https://doi.org/10.1093/ajhp/zxaa220 | |
Truong L, Whitfield K, Nickerson-Troy J, Francoforte K. Drivethru anticoagulation clinic: Can we supersize your care today? J Am Pharm Assoc (2003), 2021; 61(2):e65-7. https://doi.org/10.1016/j.japh.2020.10.016 | |
U.S. Department of Health & Human Services. Guidance for Licensed Pharmacists, COVID-19 Testing, and Immunity under the PREP Act. U.S. Department of Health & Human Services, Washington, DC, 2020. | |
Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: a scoping review. Res Social Adm Pharm, 2021; 17(1):1799-806. https://doi.org/10.1016/j.sapharm.2020.07.003 | |
Waldron KM, Schenkat DH, Rao KV, Campbell U. Application of emergency preparedness principles to a pharmacy department's approach to a "black swan" event: the COVID-19 pandemic. Am J Health Syst Pharm, 2021; 78(7):552-5. https://doi.org/10.1093/ajhp/zxab004 | |
Wang R, Kong L, Xu Q, Yang P, Wang X, Chen N, Li L, Jiang S, Lu X. On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: a retrospective, observational study. Res Social Adm Pharm, 2021; 17(1):1853-8. https://doi.org/10.1016/j.sapharm.2020.06.005 | |
Wieruszewski ED, Mattson AE, Manuel FC, Brown CS. Optimizing emergency medicine pharmacists' practice during the COVID-19 pandemic. J Pharm Pract, 2021; 8971900211004838. https://doi.org/10.1177/08971900211004838 | |
Yerram P, Thackray J, Modelevsky LR, Land JD, Reiss SN, Spatz KH, Levoir AC, Pak TK, Dao PH, Buege MJ, Derespiris LM, Lau C, Orozco JS, Boparai M, Koranteng LA, Reichert KE, Yan SQ, Daukshus NP, Mathew S, Buie LW, Tizon RF, Freeswick S, Liu D, Harnicar S. Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City. J Oncol Pharm Pract, 2021; 27(2):389-94. https://doi.org/10.1177/1078155220987625 | |
Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm, 2021; 17(1):1978-83. https://doi.org/10.1016/j.sapharm.2020.04.001 | |
Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Social Adm Pharm, 2021; 17(1):1819-24. https://doi.org/10.1016/j.sapharm.2020.03.012 | |
Zhou C, Pavlakos R, Clark M, Jue VI, Clinard VB. Pharmacy telehealth services: perspectives from an academic medical center. J Pharm Pract, 2021; 8971900211030652. https://doi.org/10.1177/08971900211030652 |
3 Absract views 0 PDF Downloads 3 Total views
By author names
By article title